The Strategic Dose

340B is in one of its most active policy periods in a decade, with legislation, litigation, and manufacturer policy all moving at once. In this episode of The Strategic Dose, host Lesley Pink is joined by Amanda Smith, counsel at K&L Gates, and Abel Haile, our VP of Health System Strategy and Commercial Analytics, to sort out what it all means for covered entities.The conversation covers the debate over how 340B should work rather than whether it should exist, why the undefined "patient" is the thread running through nearly every proposal, the arc of manufacturer restrictions since 2020, and HRSA's revised rebate model pilot scheduled for January 1, 2027. Amanda and Abel also look ahead to OPPS reimbursement and the growing role of state-level action, from contract pharmacy protection laws to prescription drug affordability boards.Recorded August 12, 2026. This space is moving quickly, so check current status on anything still in play.

AI is moving fast in pharmacy. The real question isn't whether to use it, but how to use it responsibly.In this episode of The Strategic Dose, host Lesley Pink sits down with two of VytlOne's own experts: Leah Bailey, General Counsel, and Kim Piant, Chief Compliance and Ethics Officer. Together they unpack what it actually takes to govern AI in a highly regulated healthcare environment, where patient safety and speed both matter.They cover the first question every new AI use case has to answer, the risks that go beyond HIPAA (like protecting clinical judgment and the cost of moving too slowly), and how VytlOne's AI Appropriate Use Committee turns enthusiasm into responsible adoption. They also look ahead to the regulatory developments they're watching, from Utah's move to let AI renew prescriptions to a proposed HIPAA Security Rule update that would bring AI systems into scope.Their message is clear. Good governance isn't a brake on innovation. It's what lets you say yes faster.Listen now.

What does it take to bring AI into health system pharmacy in a way that actually works?In this episode of The Strategic Dose: Driving Your Pharmacy Mission, host Lesley Pink sits down with Kim Tzoumakas, CEO of VytlOne, and Amrit Saxena, founder and CEO of SaxeCap, to talk through VytlAIQ, a new AI-powered pharmacy intelligence platform built specifically for health systems.They discuss why now is the right moment for AI in pharmacy, how rising 340B complexity and operational fragmentation create real risk and revenue leakage, and what health system leaders should look for in an AI solution.This is AI grounded in healthcare expertise and operational depth, built for real-world impact whether you lead a large system or a smaller hospital.

In this episode of The Strategic Dose, host Lesley Pink sits down with Maria Roberts, Director of Specialty Clinical Programs, and Alicia Morris, Director of Pharmacy and Clinical Operations, from VytlOne to explore the company’s innovative approach to specialty and rare disease care.Discover how VytlOne’s high-touch specialty pharmacy model goes beyond medication dispensing, focusing on total patient care, close coordination with clinical teams, and the development of customized clinical programs tailored to each patient’s unique journey.Maria and Alicia share insights on designing effective clinical programs for rare diseases, the importance of patient education, and leveraging real-world data when supporting new therapy launches. They discuss strategies for improving adherence, supporting patients through proactive outreach, and how collaboration with manufacturers enhances patient outcomes.The episode also highlights cutting-edge tools, including data analytics and AI, that are shaping the future of specialty pharmacy in rare disease.Listen now and subscribe for more conversations that help pharmacy leaders achieve their mission. Visit vytlone.com to learn how we help you achieve your mission: https://vytlone.com/

In this episode of The Strategic Dose: Driving Your Pharmacy Mission, host Lesley Pink chats with Tyler Clay, Senior Director of Pharmacy and Infusion Services at Conway Medical Center, and Bonnie Dugie, Vice President of Pharmacy Accreditation Services at VytlOne, to break down what specialty pharmacy accreditation really means and why it matters. They discuss why more medications are moving into the specialty space, how accreditation supports safer, more consistent patient care, and how it can unlock access to limited distribution drugs (LDDs) and payer networks.Tyler and Bonnie also share how Conway achieved dual ACHC and URAC accreditation in just 45 days with zero citations, the workflow and quality-management practices that make that possible, and what’s next as accreditation standards evolve, especially as AI becomes more embedded in healthcare and specialty pharmacy operations.Listen now and subscribe for more conversations that help pharmacy leaders achieve their mission.

Welcome to Episode 1 of The Strategic Dose by VytlOne. Episode 1 features Melissa Pitsoulakis, Vice President of Marketing, for VytlOne and Tom Sullivan, Senior Director of Editorial Services, for Sage Growth Partners. Join our host, Lesley Pink as she and our guests dive deep into the findings of our 2nd Annual Healthcare Leadership Report, Reviving Access, Reclaiming Revenue. Learn what issues are keeping hospital and health systems up at night regarding pharmacy and achieving their community mission.